Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine, Paclitaxel, and Doxorubicin with Pegfilgrastim in Metastatic TCC and Renal Insufficiency
NCT00478361Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Apr 2007
- Primary completion
- Jun 2015
- Modality
- Targeted Liposomes, Cytokines & Interferons, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, Paclitaxel Micelles for Injection, pegylated liposomal doxorubicin in transitional cell carcinoma (TCC), sponsored by University of Texas MD Anderson Cancer Center. Started Apr 2007; status: completed.
02
Drugs
gemcitabinePaclitaxel Micelles for Injectionpegylated liposomal doxorubicin
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00478361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00478361.